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Introduction
Posttranslational  modification,  including  phosphorylation, 
ubiquitination, and lipid modification, adds functional regula-
tion to proteins beyond genomic information. Lipid modifica-
tion increases protein hydrophobicity and plays a critical role   
in protein trafficking, targeting, and function. Thioester-linked 
palmitate  modifies  signaling  proteins,  enzymes,  cytoskeletal 
proteins, ion channels, and scaffolding proteins and is involved 
in diverse aspects of cellular signaling (El-Husseini and Bredt, 
2002; Resh, 2006; Linder and Deschenes, 2007). Recent global 
proteomic analyses have further expanded the known comple-
ment of palmitoylated proteins (Roth et al., 2006; Kang et al., 
2008). Palmitoylation is unique in that it is a reversible modifi-
cation and is proposed to be regulated by specific extracellular 
signals. Recent cell biological analyses revealed that some pal-
mitoyl substrates such as small GTPases, Harvey Ras/neuro-
blastoma Ras (Rocks et al., 2005), and trimeric G proteins Go 
(Chisari et al., 2007)/Gq (Tsutsumi et al., 2009) constitutively 
shuttle between the plasma membrane and the Golgi membrane 
by a palmitoylation/depalmitoylation cycle. This palmitate   
cycling  generates  and  maintains  the  specific  intracellular   
compartmentalization of substrates in nonpolarized cells (Rocks 
et al., 2006).
The postsynaptic scaffolding protein PSD-95 represents a 
major palmitoylated protein in neurons and plays critical roles 
in synaptogenesis and synaptic plasticity (Migaud et al., 1998; 
El-Husseini et al., 2000; Kennedy, 2000; Kim and Sheng, 2004; 
Funke et al., 2005). PSD-95 provides a platform for the post-
synaptic  clustering  of  crucial  synaptic  proteins,  including 
AMPA (-amino-3-hydroxy-5-methyl-4-isoxazole propionic 
  P
rotein palmitoylation is the most common posttrans-
lational lipid modification; its reversibility mediates 
protein shuttling between intracellular compartments. 
A large family of DHHC (Asp-His-His-Cys) proteins has 
emerged  as  protein  palmitoyl  acyltransferases  (PATs). 
However, mechanisms that regulate these PATs in a phys-
iological context remain unknown. In this study, we effi-
ciently  monitored  the  dynamic  palmitate  cycling  on 
synaptic scaffold PSD-95. We found that blocking syn-
aptic activity rapidly induces PSD-95 palmitoylation and 
mediates synaptic clustering of PSD-95 and associated 
AMPA (-amino-3-hydroxy-5-methyl-4-isoxazole pro-
pionic acid)-type glutamate receptors. A dendritically   
localized  DHHC2  but  not  the  Golgi-resident  DHHC3   
mediates  this  activity-sensitive  palmitoylation.  Upon   
activity blockade, DHHC2 translocates to the postsynap-
tic density to transduce this effect. These data demon-
strate that individual DHHC members are differentially 
regulated  and  that  dynamic  recruitment  of  protein   
palmitoylation  machinery  enables  compartmentalized   
regulation of protein trafficking in response to extracel-
lular signals.
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palmitoylation–deficient (CS) mutant PSD-95 or GFP (Fig. 1, A 
and B). We confirmed comparable expression levels of PSD-95 
(WT) and PSD-95 (CS) in transfected culture (Fig. 1 B). These 
data confirm that palmitoylation mediates membrane trafficking 
and synaptic clustering of PSD-95 (Topinka and Bredt, 1998). 
Because PSD-95 visualized by TIRFM apposes presynaptic 
synaptophysin and VGLUT1 and overlaps postsynaptic NR1 
NMDA receptor (Fig. 1 C), TIRFM tracks synaptic PSD-95. 
When ionotropic glutamate receptor activity was blocked by 
kynurenic acid (Kyn), the intensity of PSD-95–GFP by TIRFM 
steadily increased over 2 h, whereas the intensity of PSD-95 
(CS) did not change (Fig. 1, D and E; and Video 1). This Kyn-
induced PSD-95 increase was blocked by coapplication of   
2-bromopalmitate (2-BP), which is a palmitoyl acyl transfer in-
hibitor. PSD-95 signals did not detectably change within 2 h of 
2-BP treatment alone (Fig. 1 E). These results indicate that 
newly occurring palmitoylation mediates this synaptic accu-
mulation of PSD-95. Tetrodotoxin (TTX), a blocker of action   
potentials, also increased PSD-95 accumulation. The dynamic 
change of PSD-95 intensity was specific to palmitoylation as 
the localizations of GFP-Rac1-CLLL (Cys-Leu-Leu-Leu), a   
geranylgeranylated CaaL motif, and synaptophysin-GFP, a pre-
synaptic protein, did not change upon Kyn treatment (Fig. 1 E). 
Synaptic PSD-95 accumulation upon activity blockade was also 
confirmed by antibody staining of native PSD-95 (see Fig. 4,   
C and D). The effect of Kyn or TTX on PSD-95 accumulation 
does not reflect newly synthesized PSD-95, as cycloheximide 
(CHX),  an  inhibitor  of  protein  synthesis,  did  not  affect  the   
Kyn- or TTX-induced PSD-95 increase (Fig. S1, A and B; and 
Video 2). Thus, PSD-95 palmitoylation increases at the post-
synaptic membrane upon activity blockade. These results are 
complementary to receptor activation–induced depalmitoylation 
of PSD-95 (El-Husseini et al., 2002).
The DHHC2/15 subfamily of PSD-95 
palmitoylating enzymes is regulated by 
synaptic activity
To monitor PSD-95 palmitoylation biochemically, we used the 
acyl-biotin exchange (ABE) method (Roth et al., 2006; Kang   
et al., 2008). We confirmed that this method specifically identi-
fied palmitoylated proteins, including PSD-95, in heterologous 
cells (Fig. S2 A). As previously reported (El-Husseini et al., 
2002), treating neurons for 12 h with 2-BP reduced PSD-95   
palmitoylation (palmitoylated PSD-95 = 13 ± 15% of control 
cells; P < 0.001; Fig. 2 A). When we treated neurons for 2 h   
with Kyn, the amount of palmitoylated PSD-95 significantly in-
creased (198 ± 13% of control cells; P < 0.001; Fig. 2, A and B). 
Blocking glutamate receptors with a combination of APV   
(D-[-]-2-amino-5-phosphonopentanoic acid), which blocks NMDA 
receptors, and CNQX (6-cyano-7-nitroquinoxaline-2,3-dione), 
which blocks AMPARs, also enhanced PSD-95 palmitoylation 
within 2 h (palmitoylated PSD-95 = 184 ± 23% of control cells; 
P < 0.01). 2-BP blocked the rapid enhancement of PSD-95   
palmitoylation, indicating that inhibition of depalmitoylation is 
not solely responsible and that newly occurring palmitoylation 
mediates this effect. This activity-sensitive PSD-95 palmitoylation 
is stoichiometric, as Kyn and APV + CNQX quantitatively 
acid) and N-methyl-d-aspartate (NMDA)-type glutamate recep-
tors and cell adhesion molecules. The postsynaptic targeting of 
PSD-95 depends on protein palmitoylation (Topinka and Bredt, 
1998). Importantly, palmitate cycling on PSD-95 is dynami-
cally regulated by receptor activation (El-Husseini et al., 2002). 
Upon glutamate receptor stimulation, accelerated depalmi-
toylation  of  PSD-95  dissociates  PSD-95  from  postsynaptic 
sites and causes AMPA receptor (AMPAR) endocytosis. This 
receptor activation–induced depalmitoylation has also been re-
ported in G (Wedegaertner and Bourne, 1994). Thus, agonist-
dependent depalmitoylation down-regulates synaptic strength 
and G protein signaling. However, it is not yet clear whether   
addition of palmitate to proteins is accelerated in response to 
extracellular signals.
The dynamic regulation of palmitate cycling should be 
finely tuned by palmitoyl acyltransferases (PATs) and palmitoyl 
protein thioesterases (PPTs). Transmembrane proteins con-
taining a DHHC (Asp-His-His-Cys) Cys–rich domain (DHHC   
proteins) have recently emerged as PATs in yeast (Bartels   
et al., 1999; Lobo et al., 2002; Roth et al., 2002; Linder and   
Deschenes, 2004). At least 23 mammalian DHHC proteins   
exist, and a systematic screening method has identified specific 
enzyme–substrate pairs (Fukata et al., 2004; Fang et al., 2006; 
Fernandez-Hernando et al., 2006; Fukata et al., 2006; Ponimaskin 
et al., 2008; Tsutsumi et al., 2009). The DHHC family is present 
in species ranging from yeast to human and to plants (Hemsley 
et  al.,  2005;  Hemsley  and  Grierson,  2008).  Several  DHHC 
genes are associated with diseases, including cancers (Oyama   
et al., 2000), schizophrenia (Mukai et al., 2004, 2008), mental 
retardation (Mansouri et al., 2005; Raymond et al., 2007), and 
Huntington’s (Yanai et al., 2006). Although the large DHHC 
family plays essential roles in a range of physiological func-
tions, how the DHHC PAT family is regulated and thereby   
dynamically controls palmitate cycling remains uncertain.
In this study, we found that suppression of neuronal 
  activity induces palmitoylation and synaptic accumulation   
of  PSD-95.  This  activity-sensitive  PSD-95  palmitoylation   
recruits synaptic AMPARs. Dendritically localized DHHC2 
mediates this rapid synaptic palmitoylation of PSD-95. In 
contrast, Golgi-resident DHHC3 constitutively palmitoylates 
PSD-95. These experiments indicate that large DHHC family 
members  are  individually  regulated,  which  enables  their   
participation in specific physiological processes such as syn-
aptic plasticity.
Results
Total internal reflection fluorescence 
microscopy (TIRFM) reveals the  
synaptic accumulation of PSD-95  
upon activity blockade
To follow changes in synaptic PSD-95 accumulation over time, 
we first performed time-lapse imaging of cultured hippocampal 
neurons  transfected  with  PSD-95–GFP  by  TIRFM,  which   
excites only molecules within 100 nm of the cover glass. TIRFM 
preferentially visualizes wild-type (WT) PSD-95–GFP as dis-
crete punctae on dendrites, which are not seen with cytosolic 149 DHHC ENZYME REGULATED BY SYNAPTIC ACTIVITY • Noritake et al.
Figure 1.  TIRFM imaging of activity-sensitive PSD-95 palmitoylation. (A) Compared with epifluorescent microscopy (Epi; green), TIRFM selectively reveals 
punctae from GFP-tagged PSD-95 (WT) (top; red) but not palmitoylation-deficient PSD-95 (CS) (bottom; red) in cultured hippocampal neurons. To define 
dendritic morphology, we coexpressed mCherry (Epi; blue). (B) TIRFM preferentially visualizes PSD-95 (WT)–GFP punctae as compared with PSD-95 
(CS)–GFP or GFP alone. n = 10 neurons; ***, P < 0.001. Comparable expression levels of PSD-95 (WT)– and PSD-95 (CS)–GFP in transfected neuron 
culture were confirmed. (C) TIRFM tracks synaptic PSD-95. PSD-95 punctae (green) visualized by TIRFM apposed presynaptic synaptophysin and VGLUT1 
and overlapped postsynaptic NR1. (D) PSD-95–GFP dynamics were analyzed by time-lapse TIRFM imaging. Inhibition of glutamate receptor activity with 
10 mM Kyn increased PSD-95 (WT)–GFP intensity within 2 h. In contrast, the palmitoylation-deficient mutant PSD-95 (CS) did not change. Kymographs 
represent the changes in the intensity of PSD-95–GFP over 2 h. White lines indicate the regions used for the kymographs. (E) Synaptic accumulation of 
PSD-95 depends on newly occurring palmitoylation. Fluorescent intensities of PSD-95–GFP (WT and CS), GFP containing a C-terminal prenylation CaaL 
motif of Rac1 (GFP-CLLL), and synaptophysin-GFP (Syn-GFP) at 2 h after the indicated treatments were quantified. The intensity of PSD-95 (WT)–GFP but not   
other membrane-targeting proteins significantly increased upon 10 mM Kyn or 2 µM TTX treatment. Coapplication of 100 µM 2-BP with Kyn completely   
inhibited Kyn-induced increase of PSD-95–GFP intensity. n = 3–8 experiments; ***, P < 0.001 compared with control. (B and E) Error bars indicate SD. 
Bars: (A) 10 µm; (C and D) 5 µm.JCB • VOLUME 186 • NUMBER 1 • 2009   150
DHHC3  and  -7  (Tsutsumi  et  al.,  2009),  and  GluR2  PAT  is 
DHHC3  (Fig.  S2  C;  Hayashi  et  al.,  2005).  These  substrate   
selectivities allowed us to ask whether synaptic activity regu-
lates a specific PAT subfamily (i.e., DHHC2/15). We metaboli-
cally labeled hippocampal neurons with [
3H]palmitic acid for   
2 h in the presence or absence of Kyn. We found that Kyn-
  enhanced PSD-95 palmitoylation was partially blocked by a   
dominant-negative (DN) mutant, DN-DH2/15, which specifi-
cally inhibits the DHHC2/15 subfamily (palmitoylated PSD-95 = 
61 ± 15% of Kyn-treated control cells; P < 0.01; Fig. 2 D; Fukata   
et al., 2004). The partial effect of DN-DH2/15 is probably 
caused by the infection efficiency of DN-DH2/15. Under our 
conditions,  50%  of  neurons  were  expressing  DN-DH2/15, 
shifted the PSD-95 band upward (Fig. 2, A and B; Fig. S1 C; 
and Fig. S2 B). This upward shift reflects palmitoylation, as 
-mercaptoethanol  (ME),  which  hydrolyses  the  palmitoyl 
thioester, leaves only the lower band (Fig. 2, A and B, bottom). 
Both the increased PSD-95 palmitoylation and synaptic accu-
mulation were reversible upon washing out of Kyn, indicating 
that this process is activity sensitive (Fig. 2, B and C).
This activity-sensitive palmitoylation is specific for PSD-95, 
as Gq, GluR2, and GRIP1 palmitoylation did not change   
upon activity blockade (Fig. 2, A and B). Our previous study 
demonstrated that PSD-95 PATs are DHHC2, -3, -7, and -15, 
which  are  phylogenetically  divided  into  two  subfamilies, 
DHHC3/7 and DHHC2/15 (Fukata et al., 2004). Gq PATs are 
Figure 2.  The DHHC2/15 subfamily of PSD-95 PATs is regulated by synaptic activity. (A) Activity blockade induces quantitative palmitoylation of PSD-95 
but not Gq. Hydroxylamine (H)-sensitive palmitoylated proteins were purified from treated neurons by the ABE method. The amount of palmitoylated 
PSD-95 and Gq was analyzed by Western blotting. T, Tris treatment as a control of hydroxylamine. (B and C) Kyn-induced PSD-95 palmitoylation and 
synaptic accumulation were reversible upon washing out Kyn. (B) Treatment of hippocampal neurons with Kyn for 2 h enhanced PSD-95 palmitoylation. 
After washout, PSD-95 palmitoylation level returned to the basal level within 2 h (ABE), with consistent mobility change of PSD-95 (ME). In contrast, 
Gq, GluR2, and GRIP1 palmitoylation did not change upon activity blockade. Kyn-induced palmitoylation changes were quantified. n = 3 each; ***, P < 
0.001. Error bars indicate SD. The dashed line (100%) indicates the normalized control level. IB, immunoblot. (A and B) Closed and open arrows indicate 
the positions of palmitoylated and nonpalmitoylated PSD-95, respectively. (C) The increased accumulation of PSD-95–GFP upon Kyn treatment returned 
to the basal level at 2 h after Kyn washout. (D) Cultured hippocampal neurons expressing a DN mutant of the DHHC2 and -15 subfamily (DN-DH2/15) 
were treated with 3 mCi/ml [
3H]palmitate for 2 h in the presence or absence of Kyn. Immunoprecipitated PSD-95 was resolved by SDS-PAGE, followed 
by fluorography ([
3H]palm) and Coomassie staining (CBB). Inhibition of glutamate receptor activity with Kyn greatly enhanced PSD-95 palmitoylation. This 
enhancement was decreased by DN-DH2/15. IP, immunoprecipitation. Bar, 5 µm.151 DHHC ENZYME REGULATED BY SYNAPTIC ACTIVITY • Noritake et al.
DHHC2  or  -3  knockdown  by  microRNA  (miRNA; 
miDHHCs) greatly reduced the number of PSD-95 punctae 
(Fig. 4, A and B). Importantly, knockdown of DHHC2 but not 
DHHC3 prevented Kyn- or TTX-induced increase of endogenous 
PSD-95 accumulation at synaptic sites (Fig. 4, A, C and D) and 
Kyn-induced augmentation of PSD-95–GFP accumulation (Fig. 5 
and Video 3). The inhibitory effect of miDHHC2 was rescued 
by miDHHC2-resistant WT DHHC2 (WT) but not by PAT-inactive 
DHHC2 (CS) (Fig. 5 and Fig. S4 C). These results indicate that 
DHHC3 localizes to the Golgi apparatus and mediates constitu-
tive  palmitoylation  of  various  substrates,  including  PSD-95, 
Gq, and GABAA receptor- subunit (Fukata et al., 2004; Keller 
et al., 2004; Tsutsumi et al., 2009). In contrast, dendritic DHHC2 
mediates activity-sensitive PSD-95 palmitoylation.
Dendritic DHHC2 translocates near 
postsynaptic sites upon activity blockade
We next investigated whether DHHC2 PAT activity, monitored 
by autopalmitoylation (Fukata et al., 2004), was regulated by 
synaptic activity. Whereas PSD-95 palmitoylation increased 
which correlates with the extent of inhibition (40% inhibi-
tion). Although  the  involvement  of  other  PATs  cannot  be   
completely ruled out, our results strongly suggest that the 
DHHC2/15 subfamily plays a major role in activity-sensitive 
PSD-95 palmitoylation.
Differential regulation of PSD-95 
palmitoylating enzymes in neurons
We next examined the cellular locus for PSD-95 palmitoylation. 
We focused on DHHC2 and -3, as hippocampal neurons express 
these PATs but much less DHHC7 and -15 (Fig. S3 A). Immuno-
blotting with specific antibodies (Fig. 3 A) showed that DHHC2 
occurred in the postsynaptic density fraction, whereas DHHC3 
was present only in the P3 fraction, which contains Golgi proteins 
(Fig.  3  B).  Consistent  with  this  finding,  DHHC3  specifically   
localizes to the somatic Golgi apparatus (Keller et al., 2004;   
Tsutsumi et al., 2009), whereas DHHC2 distributes in the dendrites 
and cell body as small vesicular-like structures (Fig. 3 C). These 
signals are specific, as the staining completely disappeared in the 
validated knockdown vector–transfected neuron (Fig. 3 D).
Figure  3.  Differential  subcellular  distribution  of  PSD-
95 palmitoylating enzymes. (A) Specificity of antibodies 
to DHHC2 and -3. The bands detected by anti-DHHC2 
(closed arrowheads) and anti-DHHC3 (open arrowhead) 
antibodies  disappeared  when  protein  expression  was 
knocked down by siRNAs. IB, immunoblot; scr, scram-
ble. (B) DHHC2 was enriched in the postsynaptic den-
sity (PSD) fractions (Triton X-100–insoluble postsynaptic; 
closed arrowheads), whereas DHHC3 was detected in 
only the P3 fraction (open arrowhead). H, homogenate; 
S,  supernatant;  P,  precipitate;  Syn,  synaptosome;  Sol, 
Triton X-100 soluble; Ins, Triton X-100–insoluble postsyn-
aptic density fractions. (C) DHHC2 localized in dendrites 
and the cell body as small vesicular structures, whereas 
DHHC3 specifically localized at the Golgi apparatus in 
18-DIV hippocampal neurons. (D) Effective knockdown   
of  endogenous  DHHC2  and  -3.  Cultured  hippocampal 
neurons  were  transfected  with  mCherry-miR  RNAi   
(miDHHC2 and -3) expression vectors at 10 DIV. 18-DIV   
neurons  were  stained  by  DHHC2  or  -3  antibody. 
Note that somatodendritic DHHC2 vesicles and Golgi 
DHHC3 (arrows) were not stained in mCherry-expressing   
knocked down neurons (red). Bars: (C [left] and D) 20 µm; 
(C [right]) 5 µm.JCB • VOLUME 186 • NUMBER 1 • 2009   152
pHluorin-tagged GluR1 (pH-GluR1) subunit (Ashby et al., 
2004; Yudowski et al., 2007) and TIRFM imaging to monitor 
specifically surface-expressed GluR1 (Video 5). pH-GluR1 
punctate intensity was invariant over 12 h (Fig. 7, A and D; 
and Video 6). In contrast, TTX treatment gradually and con-
tinually increased pH-GluR1 intensity (Fig. 7, B and D; and 
Video  7).  By  post  hoc  immunostaining  with  PSD-95,  we 
found that pH-GluR1 punctae by TIRFM completely over-
lapped PSD-95 clusters (Fig. 7 C). Furthermore, knockdown 
of DHHC2 or PSD-95 completely blocked this increase of 
pH-GluR1 intensity (Fig. 7, D and E). The effect of DHHC2 
knockdown was rescued by miDHHC2-resistant WT DHHC2 
(WT) but not by PAT-inactive DHHC2 (CS) (Fig. 7 E and 
Video 8). The effect of PSD-95 knockdown was rescued by 
short hairpin RNA–resistant WT PSD-95 (WT) but not by 
palmitoylation-deficient PSD-95 (CS) (Fig. 7 E, Fig. S4 D, 
and Video 9). We also found that knockdown of DHHC2 or 
PSD-95 similarly inhibited Kyn-induced increase of pH-GluR1 
(Fig. 7 D). pH-GluR2, endogenous GluR1, GluR2, and stargazin-
like TARPs but neither NR2A NMDA receptor nor VGLUT1 
showed an increase similar to that of pH-GluR1 (Fig. S5).   
upon TTX or Kyn treatment, autopalmitoylation of DHHC2   
and -3 did not change (Fig. 6 A), suggesting that DHHC2 activity 
may remain constant. We then investigated whether DHHC2   
localization is regulated by synaptic activity. TIRFM imaging 
revealed that more DHHC2 was recruited near the membrane 
upon Kyn or TTX treatment (Fig. 6, B and C; and Video 4), 
where PSD-95 localized (Fig. S4 A). This translocation was   
activity sensitive as it was reversible upon washing out of Kyn 
(Fig. 6 D). Furthermore, we found that Kyn or TTX steadily   
induced colocalization of endogenous DHHC2 with PSD-95 
over 48 h (Fig. 6, E and F), whereas DHHC3 remained at the 
Golgi apparatus (Fig. S4 B).
Activity-sensitive PSD-95 palmitoylation 
by DHHC2 is necessary for homeostatic 
increase of AMPARs
Because PSD-95 anchors AMPARs at the postsynaptic sites 
through  interaction  with  stargazin  and  related  transmem-
brane AMPAR regulatory proteins (TARPs; Chen et al., 2000; 
Nicoll  et  al.,  2006),  we  investigated  changes  in  synaptic   
AMPARs upon activity blockade. We took advantage of the 
Figure 4.  DHHC2 and -3 are differently involved in PSD-95 trafficking. (A and B) In the DHHC2 or -3 knocked down neurons (labeled with mCherry), 
the number of native PSD-95 puncta (green) was significantly decreased. n = 5 neurons; ***, P < 0.001. (C and D) Knockdown of DHHC2 but not 
DHHC3 prevented TTX- or Kyn-induced augmentation of endogenous PSD-95 accumulation. Dashed lines (100%) indicate the normalized control level.   
***, P < 0.001. (C) Analyzed by confocal laser-scanning microscopy (CLSM). n = 10–15 neurons. (D) Analyzed by TIRFM. n = 5 neurons. miLacZ is a 
control miRNA targeting LacZ (-galactosidase). (B–D) Error bars indicate SD. Bar, 5 µm.153 DHHC ENZYME REGULATED BY SYNAPTIC ACTIVITY • Noritake et al.
Similar inhibitory effects of DHHC2 or PSD-95 knockdown 
were observed for endogenous GluR1, GluR2, and TARPs 
(Fig. S5 G). These results indicate that activity-sensitive PSD-95 
palmitoylation by DHHC2 mediates the homeostatic increase 
of AMPARs.
Discussion
By  contrasting  two  representative  PSD-95  palmitoylating   
enzymes, this study is the first to define differential regulation 
of DHHC-type palmitoylating enzymes. DHHC3 stably local-
izes  at  the  Golgi  apparatus  and  constitutively  palmitoylates   
numerous substrates, including G, GluR2, and PSD-95. In 
contrast, dendritically localized DHHC2 senses changes in 
synaptic activity and rapidly translocates near postsynaptic 
membranes. Synaptically translocated DHHC2 induces rapid, 
specific, and stoichiometric palmitoylation and synaptic accu-
mulation of PSD-95 and thereby AMPAR recruitment at post-
synaptic sites. Thus, activity-sensitive DHHC2 translocation 
marks sites for AMPAR accumulation through compartmental-
ized PSD-95 palmitoylation. Complementing these findings, 
previous  works  showed  that  the  Drosophila  melanogaster 
DHHC17/HIP14 homologue localizes primarily to presynap-
tic terminals and acts on presynaptic Cys string protein and   
SNAP-25 (Ohyama et al., 2007; Stowers and Isacoff, 2007). 
The  DHHC  family  members  show  distinctive  subcellular   
distributions and different intracellular dynamics upon physio-
logical stimuli. These distinctive properties provide mecha-
nisms for specific control of protein palmitoylation by the large 
family of DHHC proteins.
Recent  fluorescence  recovery  after  photobleaching  and 
photoconversion analyses revealed that several palmitoylated   
proteins such as Harvey Ras/neuroblastoma Ras (Rocks et al., 
2005), Go (Chisari et al., 2007), and Gq (Tsutsumi et al., 
2009) rapidly shuttle between the plasma membrane and the 
Golgi  apparatus.  This  constitutive  shuttling  comprises  four 
steps: (1) palmitoylation by the Golgi-resident DHHC proteins, 
(2) trafficking to the plasma membrane, (3) depalmitoylation by 
a putative PPT and rapid cytosolic diffusion, and (4) transient 
trapping at the Golgi for repalmitoylation (Fig. 8 A; Rocks   
et al., 2006; Tsutsumi et al., 2009). In neurons, where the Golgi 
apparatus is segregated from the axon and dendrites, we suggest 
that Golgi-localized DHHC3 mediates the constitutive palmi-
toylation of PSD-95 at the cell body. In dendrites, PSD-95   
depalmitoylated at the postsynaptic membrane diffuses from 
dendritic spine to shaft, is repalmitoylated on DHHC2-positive 
vesicles, and is redirected to postsynaptic membranes (Fig. 8 B). 
When synaptic activity is blocked, DHHC2 vesicles translocate 
from dendritic shafts to sites near the postsynaptic membrane. 
This allows DHHC2 to repalmitoylate PSD-95 in the spine 
(Fig. 8 C). Thus, mobile DHHC2 induces a local increase of 
PSD-95 palmitoylation, which leads to AMPAR recruitment. 
We propose that extracellular signals translocate specific DHHC 
PATs and create a new route for substrate shuttling between loci 
of palmitoylation and depalmitoylation, leading to efficient and 
precise substrate targeting. Such a compartmentalized regula-
tory mechanism of DHHC PATs may contribute to spatiotemporal 
Figure 5.  DHHC2 is essential for activity-sensitive PSD-95 palmitoylation. 
(A and B) DHHC2 but not DHHC3 mediates palmitoylation of PSD-95 
upon activity blockade. Knockdown of DHHC2 but not DHHC3 inhibited 
Kyn-induced  PSD-95–GFP  recruitment  at  the  synaptic  membrane.  miD-
HHC2-resistant DHHC2 (WT) but not PAT-inactive DHHC2 (CS) rescued 
Kyn-induced PSD-95 accumulation. (A) TIRFM intensity of representative 
five punctae from a neuron was plotted with time. (B) n = 3 each; ***, P < 
0.001. Error bars indicate SD. Bar, 5 µm.JCB • VOLUME 186 • NUMBER 1 • 2009   154
supplemented with epifluorescent and confocal microscopic 
analyses  on  endogenous  PSD-95.  Also,  our  biohemical  ap-
proaches, including metabolic labeling and the ABE method, 
showed that blocking synaptic activity quantitatively increases 
endogenously palmitoylated PSD-95, supporting the specificity 
of TIRFM imaging as a method for monitoring palmitoylated 
proteins in living cells.
A previous study reported that glutamate receptor acti-
vation accelerates depalmitoylation of PSD-95, dissociates 
PSD-95 from postsynaptic sites, and causes AMPAR endocytosis   
regulation of signaling molecules in polarized neurons, epithe-
lial cells, and migrating cells.
This study monitors intracellular dynamics of palmi-
toylated proteins by taking advantage of time-lapse TIRFM, 
which visualizes membrane-associated proteins with exquisite 
sensitivity. This approach allowed us to follow dynamic changes 
in membrane-associated PSD-95–GFP over time in individual 
neurons. However, one may ask whether endogenous PSD-95 
shows  similar  dynamics  and  whether TIRFM  visualizes  a   
limited set of synaptic contacts. The TIRFM limitation was 
Figure 6.  Activity-sensitive synaptic translocation of DHHC2. (A) No change in DHHC autopalmitoylation (detected by the ABE method) was seen upon 
activity blockade (TTX or Kyn) of hippocampal neurons, suggesting that DHHC activity remains constant. (B and C) TIRFM imaging revealed that treatment 
with Kyn or TTX translocated DHHC2-GFP near the plasma membrane. n = 3; *, P < 0.05; **, P < 0.01 compared with control. Kymographs (pseudo-
color) represent the changes in the intensity of DHHC2-GFP over time. (D) The translocation of DHHC2-GFP induced by Kyn treatment was reversible upon 
washing out Kyn. (E and F) Colocalization of endogenous DHHC2 with PSD-95 steadily increased over prolonged TTX or Kyn treatment. (F) n = 5–7 each;   
**, P < 0.01; ***, P < 0.001. (C and F) Error bars indicate SD. Bars: (B) 2 µm; (D) 5 µm; (E [left]) 3 µm; (E [right]) 1 µm.155 DHHC ENZYME REGULATED BY SYNAPTIC ACTIVITY • Noritake et al.
Figure 7.  Essential role of DHHC2-mediated PSD-95 palmitoylation in AMPAR homeostasis. (A and B) Upon 2 µM TTX treatment, TIRFM intensity of   
pH-GluR1 punctae gradually and continually increased over a 12-h observation. Fluorescence intensity was displayed in pseudocolor and was plotted with 
time. Kymographs represent the changes in the intensity of pH-GluR1. White lines indicate the regions used for the kymographs. Insets are magnified 
in the middle panels. (C) Post hoc immunostaining with PSD-95 showed that all GluR1 punctae by TIRFM overlapped synaptic PSD-95 clusters (arrows).   
(D) Quantification of fluorescent intensities of pH-GluR1 by TIRFM at 12 h after TTX or Kyn treatment. Knockdown of DHHC2 or PSD-95 completely inhibited 
the homeostatic increase of surface GluR1. n = 3 each; ***, P < 0.001 compared with nontreated control. miLacZ is a control miRNA targeting LacZ.   
(E) The inhibitory effect of DHHC2 knockdown was rescued by miDHHC2-resistant DHHC2 (WT) but not by PAT-inactive DHHC2 (CS). Furthermore, the inhibi-
tory effect of PSD-95 knockdown was rescued by short hairpin RNA–resistant PSD-95 (WT) but not by palmitoylation-deficient PSD-95 (CS). n = 3 for each;   
***, P < 0.001. (D and E) Error bars indicate SD. Bars: (A and B [top] and C) 10 µm; (A and B [insets]) 0.5 µm; (A and B [bottom] and E) 5 µm.JCB • VOLUME 186 • NUMBER 1 • 2009   156
Recently, it was shown that both PSD-95 and PSD-93 
play important roles in AMPAR trafficking (Elias et al., 2006). 
In this study, we found that knockdown of PSD-95 alone   
completely blocks the TTX- or Kyn-induced recruitment of 
AMPARs to the synapse. One may wonder why knockdown   
of PSD-95 alone completely blocks the TTX- or Kyn-induced 
AMPAR recruitment. We quantified expression levels of PSD-95 
and PSD-93 in our cultured 18-d in vitro (DIV) hippocampal 
neurons by quantitative Western blotting. We found that PSD-95 
expresses about eight times as much as PSD-93 (Fig. S3 B). 
Furthermore, we found that PSD-93–, one of the major PSD-93 
isoforms (Firestein et al., 2000; Parker et al., 2004), is specifi-
cally palmitoylated by the DHHC3 and -7 subfamily but not 
(El-Husseini et al., 2002). This sequence suggested that a   
PPT serves as the regulatory trigger. In contrast, our work dem-
onstrates that activity blockade–induced PSD-95 palmitoylation 
up-regulates  synaptic AMPARs.  Thus,  the  palmitoylation/
depalmitoylation cycle of PSD-95 bidirectionally contributes   
to AMPAR  homeostasis  (O’Brien  et  al.,  1998; Turrigiano   
et al., 1998; Stellwagen and Malenka, 2006). By analogy,   
-adrenergic receptor activation markedly accelerates depalmi-
toylation of Gs, shifts Gs to the cytoplasm, and down-regulates 
-adrenergic receptor–mediated signaling (Wedegaertner and 
Bourne, 1994). Collectively, these studies suggest that palmi-
tate cycling may generally mediate homeostasis of receptor-
mediated signaling.
Figure 8.  Model for compartmentalized synaptic palmitoylation of PSD-95 by mobile DHHC2. (A) Certain palmitoylated proteins such as the G subunit 
shuttle between the plasma membrane and the Golgi in nonpolarized cells. Golgi-resident DHHC3 and a putative PPT at the plasma membrane can mediate 
this constitutive shuttling. In neurons, DHHC3 localizes at the Golgi apparatus and mediates constitutive palmitoylation of various substrates, including G 
and PSD-95. (B and C) PSD-95 shuttling in dendrites. (B) A dynamic equilibrium exists between palmitoylated postsynaptic PSD-95 and nonpalmitoylated 
cytosolic PSD-95. Depalmitoylated PSD-95 diffuses into the spine and dendritic shaft. DHHC2 PAT mainly localizes in dendritic shafts on vesicles and medi-
ates dendritic PSD-95 palmitoylation. PSD, postsynaptic density. (C) When synaptic activity is blocked, DHHC2 vesicles move into spines. This translocated 
DHHC2 palmitoylates spinous PSD-95; the increased postsynaptic PSD-95 thereby contributes to AMPAR homeostasis.157 DHHC ENZYME REGULATED BY SYNAPTIC ACTIVITY • Noritake et al.
DHHC2 was also subcloned into pGW1-GFP. To obtain Thy1/pH-GluR1, 
we first inserted pHluorin between residues 21 and 22 of rat GluR1 (Tomita 
et al., 2004) and subcloned pH-GluR1 into a Thy1 expression cassette. 
pCAGGS–pH-GluR2 was made by inserting pHluorin between residues   
23 and 24 of mouse GluR2 (Fukata et al., 2005). cDNA of NR2A-GFP (Luo 
et al., 2002) was subcloned into the pCAGGS vector.
In cultured hippocampal neurons, DHHC2 and -3 were knocked 
down by the miR-RNAi system (Invitrogen). We used BLOCK-iT RNAi   
Designer (Invitrogen) to select the targeting sequences, and the following tar-
geting sequences were used (targeting both rat and human sequences):   
miDHHC2, 5-GGTGAACAATTGTGTTGGATT-3 (alternative sequence,   
5-TGTGCATAGTGTCCATGGAAA-3; both sequences yielded similar results); 
miDHHC3, 5-TGAGACGGGAATAGAACAATT-3; and miLacZ, 5-GACTA-
CACAAATCAGCGATTT-3 (as a negative control). After subcloning these 
oligonucleotides into pcDNA6.2-EmGFP-miR (Invitrogen), EmGFP was re-
placed with mCherry, and the pre-miRNA expression cassette of pcDNA6.2-
mCherry-miR (or pcDNA6.2-EmGFP-miR) was transferred to the pCAGGS 
vector with a -actin promoter. PSD-95 was knocked down as described pre-
viously (Elias et al., 2006), replacing GFP of pLLox3.7 (American Type Cul-
ture  Collection)  with  mCherry.  DHHC2  (on  pEF-Bos-HA-rat  DHHC2)  and   
PSD-95 (on pGW1-rat PSD-95–HA) rescue constructs that have two and   
four different nucleotides in the target sequences were generated by using 
site-directed mutagenesis (DHHC2, 5-GGTGAACAACTGCGTTGGATT-3;   
PSD-95, 5-TCACAATAATAGCCCAGTATA-3; changed nucleotides are   
underlined). All PCR products were analyzed by DNA sequencing.
pcDNAI-Gq-GFP was provided by C.A. Berlot (Weis Center for   
Research, Danville, PA; Hughes et al., 2001). The cDNAs of pHluorin and 
mCherry were provided by J.E. Rothman (Columbia University, New York, 
NY; Miesenbock et al., 1998) and R.Y. Tsien (University of California, San 
Diego, La Jolla, CA; Shaner et al., 2005), respectively. cDNAs of rat 
GluR1, NR2A-GFP, and pEGFP-C1-Rac1-CLLL were gifts from R. Huganir 
(Johns Hopkins University, Baltimore, MD), S. Vicini (Georgetown Univer-
sity School of Medicine, Washington, DC), and K. Kaibuchi (Nagoya Uni-
versity, Showa-Ku, Nagoya, Japan), respectively. Thy1 expression cassette 
was provided by D. Monard (Friedrich Miescher Institute, Basel, Switzer-
land; Luthi et al., 1997).
Time-lapse imaging with TIRFM
Hippocampal  neuron  cultures  were  prepared  from  rat  embryonic  day   
18–19 embryos. All animal experiments described herein were reviewed   
and approved by the ethical committee in our institutes and were performed 
according to the institutional guidelines concerning the care and handling 
of experimental animals. Neurons were seeded at a density of 2.5 × 10
5 
cells per 3.5-cm glass-based dish (Iwaki) in neurobasal medium (Invitro-
gen) supplemented with B-27 supplement (Invitrogen) and 2 mM Glutamax 
(Invitrogen). 8–10-DIV neurons were transfected by Lipofectamine 2000   
(Invitrogen)  and  observed  (18–21  DIV)  at  37°C  in  a  microincubator   
(MI-IBC-IF;  Olympus)  with  an  inverted  microscope  (IX81;  Olympus) 
equipped with a Plan-Apochromat 100× NA 1.45 oil TIRFM objective 
lens, an ImageEM charge-coupled device (CCD) camera (C9100-13; 
Hamamatsu Photonics) and Meta Imaging software version 7.1 (MDS An-
alytical Technologies). A 488-nm laser was used as a light source. Time-
lapse  images  were  taken  every  10  min  with  a  laser-based  zero  drift 
autofocusing system (IX81-ZDC; Olympus), which adjusts the focal plane 
to the initial focal plane just before each imaging frame. The video files 
(QuickTime Movie) were produced with ImageReady 2.0 (Adobe Systems, 
Inc.). To quantitate changes in PSD-95–GFP, DHHC2-GFP, or pH-GluR1 in-
tensity by TIRFM, we randomly chose fields, and the punctae (>1.25 µm in 
diameter) were quantitated in every frame. Fluorescent intensities from TIRF 
images were analyzed using MetaMorph software version 7.1 (MDS Ana-
lytical Technologies). The ratios of intensities at 0–120 min (for PSD-95 and 
DHHC2) or 0–12 h (for GluR1) in 50–100 randomly selected punctae 
(three to eight independent experiments) are shown. Kymographs were 
produced using Meta Imaging software version 7.1.
Immunofluorescence analysis of hippocampal neuron culture
Cultured hippocampal neurons (5 × 10
4 cells) were seeded onto 12-mm 
coverslips  in  24-well  dishes.  18–28-DIV  neurons  were  fixed  with  4% 
paraformaldehyde/120 mM sucrose/100 mM Hepes, pH 7.4, at room 
temperature for 10 min, permeabilized with 0.1% Triton X-100 for 10 
min, and blocked with PBS containing 10 mg/ml BSA for 10 min on ice. 
For staining of DHHC2 and VGLUT1, neurons were fixed with methanol 
for 10 min at 30°C. For mouse anti-DHHC2 antibody, Alexa Fluor 488– 
conjugated anti–mouse IgG1 subtype specific (Invitrogen) was used as a 
secondary antibody. For surface GluR1 and GluR2 staining, GluR1 and 
GluR2 receptors were “live” labeled with an antibody to an extracellular 
by the DHHC2 and -15 subfamily (Fig. S3 C), indicating that 
PSD-93– palmitoylation is differently regulated from PSD-95 
palmitoylation. Furthermore, it was reported that palmitoylation 
of PSD-93– and PSD-93– is not necessary for their postsyn-
aptic targeting (Firestein et al., 2000). Collectively, we conclude 
that PSD-95 plays a major role in DHHC2-mediated AMPAR 
recruitment upon activity blockade.
Global proteomic studies indicate that palmitoylation   
represents  a  common  posttranslational  modification  (Roth   
et al., 2006; Kang et al., 2008). Importantly, many palmitoylated   
proteins are key signaling molecules that subserve physiological 
processes. Furthermore, mutations of DHHC family members 
have been detected in cancers (Oyama et al., 2000; Mansilla   
et al., 2007; Yamamoto et al., 2007) and neurological disorders 
(Mukai et al., 2004, 2008; Mansouri et al., 2005; Yanai et al., 
2006; Raymond et al., 2007). Elucidation of molecular mecha-
nisms for palmitoylation lays a foundation to understand its role 
in physiological and pathological conditions. Because DHHC 
enzymes  show  substrate  specificity,  DHHC  PATs  represent   
exciting therapeutic targets. Our experiments of differential par-
titioning and regulation on DHHC PATs should serve as a proto-
type for understanding how dynamic protein palmitoylation is 
regulated in divergent signaling environments.
Materials and methods
Materials
The  following  antibodies  were  used:  rabbit  polyclonal  antibodies  to 
DHHC3/GODZ (Abcam), Gq (Santa Cruz Biotechnology, Inc.), GluR1 
(EMD; Millipore), GRIP1 (Millipore), PSD-93 (Millipore), and stargazin/
TARP (Millipore); a guinea pig polyclonal antibody to VGLUT1 (Millipore); 
and mouse monoclonal antibodies to -catenin (BD), GluR2 (Millipore), HA 
(Covance), NMDAR1 (Millipore), PSD-95 (Thermo Fisher Scientific), and 
synaptophysin (Sigma-Aldrich). Anti–PSD-93 antibody was raised against 
(aa 336–379) and detected all isoforms of PSD-93. Rabbit polyclonal anti-
bodies to GFP, PSD-95, and moesin were raised against GFP (aa 1–239), 
GST–PSD-95 (aa 1–434), and GST-moesin (aa 307–577), respectively, 
and affinity purified. A mouse monoclonal antibody to DHHC2 was raised 
by a baculovirus display method, which is useful for the production of anti-
bodies against membrane proteins (Masuda et al., 2003; Saitoh et al., 
2007). The following reagents were used: Kyn and APV (Tocris); TTX   
(Nacalai Tesque, Inc.); CNQX and CHX (Sigma-Aldrich); and 2-bromo-
hexadecanoic acid (2-BP; Fluka).
For knockdown experiments in HEK293 cells, siRNAs from QIAGEN 
were used: scramble (Allstars negative control), siDHHC2, and siDHHC3. 
siRNA and plasmid-based miRNA for DHHCs were validated by two meth-
ods: (1) reduced expression of exogenously expressed DHHC proteins in 
HEK293 cells (Western blotting) and (2) down-regulation of endogenous 
mRNAs in HEK293 cells (quantitative real-time PCR).
Cloning and plasmid constructions
The  rat  cDNAs  of  synaptophysin  (GenBank/EMBL/DDBJ  accession  no. 
NM_012664), DHHC2 (GenBank/EMBL/DDBJ accession no. AF228917), 
DHHC3 (GenBank/EMBL/DDBJ accession no. NM_001039014), DHHC7 
(GenBank/EMBL/DDBJ accession no. NM_133394), and DHHC15 (Gen-
Bank/EMBL/DDBJ accession no. AY886531) were cloned from rat brain 
total RNA by RT-PCR. Synaptophysin was subcloned into pCAGGS-GFP, 
and  DHHC2,  -3,  -7,  and  -15  were  subcloned  into  pEF-Bos-HA  and 
pcDNA3.1. The mutant rat DHHC2(C156S) was generated by using site-
directed mutagenesis. pGW1-rat PSD-95–GFP, pGW1-rat PSD-93–-GFP 
and pEF-Bos-HA-mouse DHHC constructs were described previously (El-
Husseini et al., 2002; Fukata et al., 2004; Parker et al., 2004). pGW1–
PSD-95–HA was constructed by replacing a GFP fragment with a synthetic 
DNA fragment encoding HA. pEGFP-C1-Rac1-CLLL was described previ-
ously (Nakagawa et al., 2001). To obtain the antigen for antibody produc-
tion, DHHC2 was subcloned into the pcDNA-His-Flag vector. His-Flag–tagged 
DHHC2  was  then  subcloned  into  pAcYM1  for  baculovirus  production. JCB • VOLUME 186 • NUMBER 1 • 2009   158
treated with Amplify (GE Healthcare) for 30 min, dried under vacuum, and 
exposed to Biomax MS (Kodak) at 80°C for 2 wk. After autoradiogra-
phy, the bands were scanned and analyzed with National Institutes of 
Health software.
Transfected HEK293 cells were preincubated for 30 min in serum-
free DME with 5 mg/ml fatty acid–free BSA (Sigma-Aldrich). Cells were 
then labeled with 0.25 mCi/ml [
3H]palmitic acid for 4 h in the preincuba-
tion medium. Cells were washed with PBS and scraped with SDS-PAGE 
sample buffer with 10 mM DTT. The cell lysate was resolved by SDS-PAGE, 
followed by fluorography (36-h exposure) and Western blotting.
In situ hybridization
In situ hybridization on 7-µm paraffin-embedded 3-wk-old rat brain sections 
(Genostaff)  was  performed  by  using  digoxigenin-labeled  RNA  probes.   
cDNAs of mouse DHHC2 (nt 1–1,098 from initiating ATG), rat DHHC3   
(nt 1–900), rat DHHC7 (nt 1–927), rat DHHC15 (nt 1–1,014), and rat 
PSD-95 (nt 1,212–1,444) were used for probe templates. An antidigoxigenin 
antibody  linked  to  alkaline  phosphatase  (Dako)  and  NBT/BCIP  (nitro   
blue  tetrazolium  chloride/5-bromo-4-chloro-3-indolyl  phosphate;  Dako) 
substrate was used to detect hybridization signals. All sections were devel-
oped for 1 h. Images were taken with a dissection microscope (SZ61; Olym-
pus) equipped with a digital camera (DP20; Olympus) and with an upright 
microscope (BX51; Olympus) equipped with a UPlan SApo 20× NA 0.75 
objective lens and a CCD camera (DP72; Olympus).
Quantitative Western blotting
Bands on blotted membranes were visualized with a cooled CCD camera 
(Light-Capture II; ATTO), and the optimal specific bands were analyzed 
with the CS Analyzer 3.0 software (ATTO). For calibration, immunopurified 
PSD-95–GFP  and  PSD-93–-GFP  from  transfected  HEK293  cells  were 
quantitated by Coomassie brilliant staining using BSA.
Subcellular fractionation
The method was basically followed as described previously (Carlin et al., 
1980). In brief, five rat adult brains were homogenized in buffer containing 
320 mM sucrose and 10 mM Hepes-NaOH, pH 7.4 (containing 0.2 mM 
PMSF). Homogenate was centrifuged for 10 min at 1,000 g to remove 
crude nuclear fraction (P1). The supernatant (S1) was centrifuged at 9,000 
g for 15 min to produce a pellet (P2) and supernatant (S2). The S2 was cen-
trifuged at 100,000 g for 1 h to produce a pellet (P3; microsomal fraction) 
and supernatant (S3). The P2 fraction was resuspended in the homogeniza-
tion buffer. Discontinuous sucrose gradients containing 3 ml of the resus-
pended P2 material and 3 ml each of 0.8, 1.0, and 1.2 M sucrose solutions 
in 10 mM Hepes-NaOH, pH 7.4, were run for 2 h at 58,000 g (SW41   
rotor; Beckman Coulter). The band between 1.0 and 1.2 M sucrose was ob-
tained as a synaptosome fraction. This synaptosome fraction was extracted 
with ice-cold 0.5% Triton X-100 in 0.16 M sucrose and 6 mM Tris-HCl, pH 
8.1, and then centrifuged at 32,800 g for 20 min to divide into soluble and 
insoluble fractions (Ins1; PSD-1). The pellet was resuspended in 0.5% Triton 
X-100, 0.16 M sucrose, and 6 mM Tris-HCl, pH 8.1, and centrifuged at 
200,000 g for 1 h to produce a pellet (Ins2; PSD-2). 50 µg of proteins of 
each fraction was analyzed by Western blotting.
Statistical analysis
The results are expressed as mean ± SD. Statistical comparisons between 
groups were performed by the Student’s t test.
Online supplemental material
Fig. S1 shows that synaptic PSD-95 accumulation upon activity blockade 
does not require protein synthesis. Fig. S2 shows the specific detection of 
PSD-95 palmitoylation by biochemical approaches. Fig. S3 shows that 
DHHC2 and -3 and PSD-95 dominantly express as compared with other 
family proteins in the hippocampus. Fig. S4 shows that DHHC2 translo-
cates near the postsynaptic sites upon activity blockade. Fig. S5 shows 
that DHHC2 and PSD-95 are necessary for homeostatic increase of GluR2 
as well as GluR1. Video 1 shows PSD-95–GFP dynamics in neurons by 
time-lapse TIRFM imaging and shows the increased accumulation of   
PSD-95–GFP upon Kyn treatment. Video 2 shows that CHX treatment does 
not inhibit Kyn-induced PSD-95–GFP increase at the synapse. Video 3 shows 
that activity-sensitive trafficking of PSD-95 is regulated by DHHC2. Video 4 
shows activity-sensitive trafficking of DHHC2. Video 5 shows the specificity 
of pH-GluR1 imaging. Video 6 shows AMPAR (pH-GluR1) dynamics by 
time-lapse TIRFM imaging. Video 7 shows that pH-GluR1 intensity gradually 
and continually increases over 12 h upon TTX treatment. Video 8 shows the 
epitope of GluR1 (EMD) or GluR2 (Millipore) by incubating neurons in 
conditioned medium for 15 min at 37°C. Neurons were then fixed with 
2% paraformaldehyde for 20 min and blocked as described above. Sur-
face GluR1 and GluR2 were visualized with Alexa Fluor 488–conjugated 
secondary antibody. Fluorescent images were taken with a confocal   
laser-scanning  microscopy  system  (LSM5  Exciter;  Carl  Zeiss,  Inc.) 
equipped with a Plan-Apochromat 63× NA 1.40 oil immersion objective 
lens. For knockdown experiments, 8–12-DIV neurons were transfected 
with pCAGGS-mCherry-miR vectors by Lipofectamine 2000. At 8–10 d 
after transfection, neurons were stained with anti-DHHC2, DHHC3, PSD-
95, GluR1, GluR2, and stargazin/TARP antibodies. To quantitate the in-
tensity of PSD-95 clusters and surface GluR1, surface GluR2, or TARP 
clusters (costained with PSD-95), we randomly chose 10–15 fields from 
two independent neuronal cultures (on treated and age-matched sister 
control cultures) and analyzed the three largest caliber proximal den-
drites (20 µm long; at least 400 clusters). We measured the mean intensi-
ties of individual clusters (>1 µm diameter) along these dendritic segments. 
Microscope control and all image analyses were performed with ZEN 
software (Carl Zeiss, Inc.). Brightness and contrast adjustments were ap-
plied to the whole image using Photoshop CS3 (Adobe Systems, Inc.). 
For some experiments, immunolabeled samples were observed by TIRFM 
and epifluorescent microscopy.
ABE method
The  ABE  method  was  performed  as  previously  described  (Roth  et  al., 
2006; Kang et al., 2008) and modified for cultured neurons. After treating 
18–28-DIV hippocampal neurons (5 × 10
5 cells/6-well dish) with the indi-
cated antagonists or inhibitors, neurons were washed with PBS containing 
10 mM N-ethyl-maleimide (NEM) twice and solubilized with 0.1 ml of lysis 
buffer (LB; 50 mM Tris-HCl, pH 7.5, 5 mM EDTA, and 50 mM NaCl) con-
taining 2% SDS and 10 mM NEM. After 15 min of extraction, LB with 2% 
Triton X-100 and 10 mM NEM was added to a final volume of 1 ml and   
incubated for 1 h at 4°C. After centrifugation at 20,000 g for 10 min, the   
supernatants were precipitated by the chloroform-methanol (CM) method 
(Wessel and Flugge, 1984). Precipitated protein was solubilized in 0.2 ml 
SB (50 mM Tris-HCl, pH 7.5, 5 mM EDTA, and 4% SDS) containing 10 
mM NEM at 37°C for 10 min. The protein was diluted into 0.8 ml LB with 
0.2% Triton X-100 and 1 mM NEM and incubated overnight at 4°C. NEM 
was removed by three sequential CM precipitations. Precipitated protein 
was solubilized in 0.2 ml of buffer SB, and then 0.8 ml HB (1 M hydroxyl-
amine, pH 7.5, 150 mM NaCl, 0.2% Triton X-100, and 1 mM biotin-
HPDP) or buffer TB (1 M Tris-HCl, pH 7.5, 150 mM NaCl, 0.2% Triton 
X-100, and 1 mM biotin-HPDP) was added. The mixture was incubated for 
1 h at room temperature and subjected to CM precipitation. The precipi-
tated protein was dissolved in 0.2 ml SB, diluted into 0.8 ml LB containing 
150 mM NaCl, 0.2% Triton X-100, and 200 µM biotin-HPDP, and incu-
bated for 1 h at room temperature. Free biotin-HPDP was removed by CM 
precipitation. The precipitated protein was solubilized in 100 µl of buffer 
UB (50 mM Tris-HCl, pH 7.5, 5 mM EDTA, and 2% SDS) and diluted in 
900 µl LB with 0.2% Triton X-100. After brief centrifugation, the super-
natant was incubated with 30 µl neutravidin-agarose (Thermo Fisher Scien-
tific) for 1 h at 4°C. After washing the beads with LB containing 0.1% SDS 
and 0.2% Triton X-100, bound proteins were suspended in SDS-PAGE 
sample buffer (62.5 mM Tris-HCl, pH 6.8, 10% glycerol, 2% SDS, and 
0.001% bromophenol blue) with 10 mM DTT (without ME; ME) and 
boiled at 90°C for 2 min. To see the palmitoylation-dependent mobility shift 
of PSD-95, the cell lysate was treated similarly (ME). To reduce the sam-
ple completely, the lysate was separately treated with SDS-PAGE sample 
buffer with 2% ME at 100°C for 5 min (+ME). Samples were subjected 
to SDS-PAGE and Western blotting with the indicated antibodies.
In vivo palmitate labeling
Hippocampal neurons were infected with Semliki forest virus to express 
GFP or GFP-tagged DN DHHC2/15 (Fukata et al., 2004). At 24 h after   
infection,  cells  were  labeled  for  2  h  in  neurobasal  media  containing   
3 mCi/ml [
3H]palmitic acid (PerkinElmer) either in the presence or absence 
of 10 mM Kyn. Labeled cells were washed with PBS and resuspended in 
0.15 ml LB A (20 mM Tris-HCl, pH 7.5, 1 mM EDTA, 100 mM NaCl, and 
1% SDS). After 5 min of extraction, 1% Triton X-100 was added to a final 
volume of 1.5 ml. After centrifugation at 20,000 g for 10 min, the super-
natants were incubated with rabbit anti–PSD-95 antibody for 1 h and then 
incubated for 1 h with 30 µl protein A–Sepharose (GE Healthcare) at 4°C. 
Immunoprecipitates were washed three times with buffer containing 20 mM 
Tris-HCl, pH 7.4, 1 mM EDTA, 100 mM NaCl, and 1% Triton X-100.   
Immunoprecipitated PSD-95 was suspended in SDS sample buffer. For   
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